Sort
51,570 grants matching “autoimmune disease”
Lentiviral Gene Therapy for Wiskott-Aldrich Syndrome
$993,911David J Rawlings · Seattle Children'S Hospital · R01 · FY2009 · AI
STING Activators as Therapy for Cancer
$993,879Glen N Barber · Stinginn, Llc · R42 · FY2023 · CA
Novel strategy to block AAV neutralizing antibody activity
$993,865Charles H Askew · Nabgen, Inc. · R42 · FY2025 · TR
NOVEL TRANSFUSION BASED IMMUNE MODULATION
$993,693Stanford University · P01 · FY2001 · HL
A MULTIDISCIPLINARY NMR CENTER FOR BIOMEDICAL RESEARCH
$993,640Chien Ho · Carnegie-Mellon University · P41 · FY2012 · EB
A polymeric biomaterial-based vaccine utilizing immunomodulatory agents and antigen for the amelioration of type 1 diabetes.
$993,629Benjamin Michael Looney · Inspira Therapeutics, Inc. · R44 · FY2021 · DK
Rapid quantification of nuclear citrullination in human neutrophils
$993,542Andrea Lynn Johnstone · Epicypher, Inc. · R44 · FY2020 · AI
Enabling risk-based testing through characterization of environmentally-Induced immune dysregulation and susceptibility to the SARS-CoV2 virus and COVID-19
$993,529Florence Burleson · · N01 · FY2021 · ES
TrialNet: Diabetes Type 1 Prevention Trial
$993,520Peter A Gottlieb · University Of Colorado Denver · U01 · FY2007 · DK
Harnessing engineered T regulatory cells to promote beta cell health in T1D
$993,436Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason · R01 · FY2022 · DK
STING Activators as Therapy for Cancer
$993,220Glen N Barber · Stinginn, Llc · R42 · FY2022 · CA
AUTOIMMUNITY CENTERS OF EXCELLENCE
$992,726Columbia University Health Sciences · U19 · FY2000 · AI
Biomarkers and Pathogenesis of Multiple Sclerosis: From Mouse to Human
$992,711Dorothy Anne Cross · Washington University · P01 · FY2012 · NS
Evaluating the impact of novel inhibitors of nuclear pore export in SLE
$992,511Sharon Tamir · Karyopharm Therapeutics, Inc. · R44 · FY2018 · AI
Regulatory Mechanisms of CD4+ T Cell Differentiation
$992,206Timothy E Reddy · Duke University · UM1 · FY2019 · HG
Genetics and pathophysiology of systemic juvenile idiopathic arthritis and other complex autoinflammatory diseases
$992,112Michael Ombrello · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2017 · AR
Targeting the checkpoint regulator VISTA for treatment of inflammatory disease
$992,040Jay L Rothstein · Immunext, Inc. · R44 · FY2018 · AI
Apoptosis
$991,981John A. Cidlowski · National Institute Of Environmental Health Sciences · ZIA · FY2015 · ES
Targeting the checkpoint regulator VISTA for treatment of inflammatory disease
$991,804Jay L Rothstein · Immunext, Inc. · R44 · FY2017 · AI
Biomarkers and Pathogenesis of Multiple Sclerosis: From Mouse to Human
$991,718Dorothy Anne Cross · Washington University · P01 · FY2008 · NS
Roles of non-Coding RNAs in Programming Lymphocyte Differentiation and Function
$991,499Stefan Muljo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Roles of RNA-binding Proteins in Programming Gene Expression in Mammals
$991,499Stefan Muljo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
i-AKC: Integrated AIRR Knowledge Commons
$991,180Lindsay G. Cowell · Ut Southwestern Medical Center · U24 · FY2025 · AI
MOLECULAR BASIS OF IDIOPATHIC DRY MOUTH
$991,020University Of Rochester · P01 · FY2004 · DE
Immune cell targeting of corticosteroids transforms the treatment of severe, chronic inflammatory diseases
$990,946Jay L Rothstein · Immunext, Inc. · R44 · FY2021 · AI